Pharma industry reports 58 deals worth $6.3 billion in February, says GlobalData
The industry reported 116 VC deals worth $3.2 billion in February 2022, compared to the last 12-month average (February 2021 to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
We envision being a leading global dermatology company in India in next 10 years
Menarini India has a presence in the dermatology and primary care segments in the Indian market with its own brands. Recently, the…
We remain optimistic that Evusheld will retain its efficacy against Omicron variant
Dr Anil Kukreja, Vice President, Medical Affairs and Regulatory, AstraZeneca India, tells Akanki Sharma about Evusheld, which was…
Convergent Finance to acquire controlling stake in Jagsonpal Pharmaceuticals
The proposed transaction will trigger a mandatory open offer for an additional 26 per cent of the outstanding shares in accordance…
Promising pipeline drugs to transform Fragile X Syndrome treatment market by 2030: GlobalData
FXS is a life-long disorder that causes a range of developmental and behavioural challenges including learning disabilities and…
Bipolar disorder market to see only modest growth due to persistent generic erosion: GlobalData
GlobalData’s latest report identifies that while there are many established products that can effectively manage acute manic…
Haplo-cord treatment may offer lasting cure for over 37.7 mn HIV patients: GlobalData
However, more research will be required to assess if this is a cure as opposed to longer-term remission
Bayer lifts peak sales estimate for prostate cancer drug
The company said it now expected more than 3 billion euros ($3.4 billion) in sales from the product in its best year
JB Chemicals and Pharmaceuticals reports revenue growth of 10 per cent to Rs 601 crores in Q3 FY22
As per IQVIA, JB was the fastest-growing company among the top 30 companies for CY 2021
China approves use of Pfizer’s COVID drug Paxlovid
It is not immediately clear if China is already in talks with Pfizer to procure the pill
Slowing trend of ANDA approvals in 2021: Pandemic effect or selective filings?
Meenu Grover Sharma, Principal Consultant, BusinessAssociar Consultants, New Delhi and Dr Professor Harvinder Popli, Director,…
Morepen Labs Q3 revenue up by 29 per cent with 14 per cent jump in Profit Before Tax
The company also witnessed 43 per cent increase in API Export
Wockhardt gets CDSCO approval to export upto 100 million doses of Sputnik vaccines
Wockhardt’s bulk vaccine and fill-finish manufacturing facilities at Waluj and Shendra, Aurangabad respectively were jointly…
Pharma industry reports deals worth $6.4 billion in January 2022
The industry reported 131 Venture Capital (VC) deals worth $4.4 billion in January 2022, compared to the last 12-month average…
Virtual Clinical Trials : A renaissance in the making
The shift towards virtual clinical trials, spurred by the pandemic, is ushering newer research models that are more convenient,…
Hester Biosciences announces Q3 and 9M FY22 results
Sales up by nine per cent and 23 per cent for Q3 and 9M FY22, respectively
China to strengthen anti-monopoly efforts in pharma industry
The action follows November’s regulatory guidelines to stamp out monopolies in Active Pharmaceutical Ingredients (APIs)
Eris Lifesciences Q3FY22 revenues at Rs 3,322 million, up seven per cent YoY
The company's EBITDA stood at Rs 1,217 million, up 13.5 per cent YoY and PAT stood at Rs 1,008 million, up 11.8 per cent YoY
Lonza’s full-year core EBITDA up 20.7 per cent on vaccine demand
Full-year core earnings before interest, tax, depreciation and amortisation (EBITDA) rose to 1.67 billion Swiss francs ($1.82…
Torrent Pharma December quarter profit slips 16 per cent to Rs 249 crores
The drugmaker had posted a net profit of Rs 297 crores in the October-December period of the 2020-21 fiscal